Get key Q3 2025 insights on Vir Biotechnology’s accelerated hepatitis delta trial milestones, strong financials, and upcoming data catalysts.

Vir Biotechnology, Inc. ( ($VIR) ) has released its Q3 earnings. Here is a breakdown of the information Vir Biotechnology, Inc. presented to its ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the CRISPR/Cas system, colloquially known as gene scissors. These can cut and ...

The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.

Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $1.17 per share versus the Zacks Consensus Estimate of a loss of $0.7. This compares to a loss of $1.56 per share a year ago. These ...

A research team led by Professor Wang Peng from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the TD Cowen ...

The 18,500-square-foot building offers industry-grade training for biotech technicians and is part of McCord's efforts to brand Generation Park as a premier life sciences hub in Houston.

Alabama Governor Kay Ivey has awarded HudsonAlpha Institute for Biotechnology over $2 million for research supporting the agriculture and forestry industries. The funding for three initiatives comes ...

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...